00000nam 2200000zi 4500 9.953689 CaOODSP 20250822090351 m o d f cr mn||||||||| 250729e20250325onc o f000 0 eng d 9780660783130 CaOODSP eng rda CaOODSP n-cn--- H14-662/2025E-PDF H14-662/2025-1E-PDF Estimation of post-acute conditions associated with COVID-19 vaccine impact and effectiveness among children and adolescents in Canada : findings report / prepared for the Public Health Agency of Canada. Ottawa, Ontario : Public Health Agency of Canada = Agence de la santé publique du Canada, March 25th, 2025. ©2025 1 online resource (88 pages) + 1 quantitative methodological report (67 pages) text txt rdacontent computer c rdamedia online resource cr rdacarrier Cover title. "Unclassified." "Supplier: Ipsos." "Contract Number: CW2348463." "Registration Number: 126-23 (HC POR 22-38). Issued also in French under title: Estimation des syndromes post-COVID-19 associés à l'impact et à l'efficacité du vaccin contre la COVID-19 chez les enfants et les adolescents au Canada : rapport des résultats. "Children and adolescents infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can develop long-term symptoms that are commonly known as post COVID-19 condition (PCC), Long COVID, or post-acute sequelae of SARS-CoV-2 infection (PASC). Numerous knowledge gaps remain about the frequency, characteristics, and risk factors that lead to PCC, along with PCC's impact on the everyday functioning and development of children and adolescents. There is an urgent need to improve the management of persons affected"--Background and research objectives, page 6. Post COVID-19 condition (Disease) Canada Public opinion. COVID-19 vaccines Canada Public opinion. Chronic diseases in children Canada Public opinion. Chronic diseases in adolescence Canada Public opinion. Public opinion Canada. Public Health Agency of Canada, issuing body. Ipsos (Firm), consultant. Estimation des syndromes post-COVID-19 associés à l'impact et à l'efficacité du vaccin contre la COVID-19 chez les enfants et les adolescents au Canada : (CaOODSP)9.953690 PDF 1.29 MB https://publications.gc.ca/collections/collection_2025/aspc-phac/H14-662-2025-eng.pdf Findings report PDF 1.14 MB https://publications.gc.ca/collections/collection_2025/aspc-phac/H14-662-2025-1-eng.pdf Quantitative methodological report HTML N/A https://epe.bac-lac.gc.ca/100/200/301/pwgsc-tpsgc/por-ef/public_health_agency_canada/2025/126-23-e/index.html Complete dataset 250168